Adapt flow cytometry methodology for patients being investigated for HES variants: use of an enlarged staining panel (including markers such as CD2, CD5, CD45RO, CD95) and acquisition of a large number of CD4+ T cells. This evidence concerns the gene CD5 and hypereosinophilic syndrome.